1. Home
  2. SNTI vs WKEY Comparison

SNTI vs WKEY Comparison

Compare SNTI & WKEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • WKEY
  • Stock Information
  • Founded
  • SNTI 2016
  • WKEY 1999
  • Country
  • SNTI United States
  • WKEY Switzerland
  • Employees
  • SNTI N/A
  • WKEY N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • WKEY EDP Services
  • Sector
  • SNTI Health Care
  • WKEY Technology
  • Exchange
  • SNTI Nasdaq
  • WKEY Nasdaq
  • Market Cap
  • SNTI 85.3M
  • WKEY 86.9M
  • IPO Year
  • SNTI N/A
  • WKEY N/A
  • Fundamental
  • Price
  • SNTI $2.26
  • WKEY $6.70
  • Analyst Decision
  • SNTI Strong Buy
  • WKEY Strong Buy
  • Analyst Count
  • SNTI 2
  • WKEY 1
  • Target Price
  • SNTI $8.50
  • WKEY $4.00
  • AVG Volume (30 Days)
  • SNTI 385.8K
  • WKEY 251.7K
  • Earning Date
  • SNTI 08-12-2025
  • WKEY 07-15-2025
  • Dividend Yield
  • SNTI N/A
  • WKEY N/A
  • EPS Growth
  • SNTI N/A
  • WKEY N/A
  • EPS
  • SNTI N/A
  • WKEY N/A
  • Revenue
  • SNTI N/A
  • WKEY $11,875,000.00
  • Revenue This Year
  • SNTI N/A
  • WKEY $18.18
  • Revenue Next Year
  • SNTI $150.00
  • WKEY $112.51
  • P/E Ratio
  • SNTI N/A
  • WKEY N/A
  • Revenue Growth
  • SNTI N/A
  • WKEY N/A
  • 52 Week Low
  • SNTI $1.52
  • WKEY $1.61
  • 52 Week High
  • SNTI $16.94
  • WKEY $14.00
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 37.88
  • WKEY 53.41
  • Support Level
  • SNTI $2.05
  • WKEY $6.21
  • Resistance Level
  • SNTI $2.35
  • WKEY $7.12
  • Average True Range (ATR)
  • SNTI 0.30
  • WKEY 0.57
  • MACD
  • SNTI 0.00
  • WKEY -0.04
  • Stochastic Oscillator
  • SNTI 20.00
  • WKEY 75.82

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

Share on Social Networks: